CD274 and neoplasm: Although blocking the binding between PD-1 with PD-L1 can enhance immune function and demonstrate sustained tumor regression and disease stabilization in various advanced cancers71, single-agent PD-L1 inhibitor treatment has not been effective in PC72–74.